鹭燕医药(002788.SZ)发布前三季度业绩，归母净利润2.2亿元，同比下降14.64%

Group 1 - The core viewpoint of the article is that Luyuan Pharmaceutical (002788.SZ) reported its Q3 2025 results, showing a slight increase in revenue but a decline in net profit [1] Group 2 - For the first three quarters, the company achieved an operating income of 15.855 billion yuan, representing a year-on-year growth of 2.87% [1] - The net profit attributable to shareholders of the listed company was 220 million yuan, reflecting a year-on-year decrease of 14.64% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was also 220 million yuan, with a year-on-year decline of 15.14% [1]